Why Canada is Becoming a Hub for Psychedelics Research and Development
FN Media Group Presents Microsmallcap.com Market Commentary
News provided by
Share this article
Share this article
NEW YORK, March 17, 2021 /PRNewswire/ Canada has become home to some of the most important research and development happening today in the mental health and wellness space. Psychedelic therapy emerged as a breakthrough mental health treatment, and Canadian companies are leading the way in developing psychedelics into safe, effective, and evidence-based treatments. Alongside leading Canadian research organizations like the Multidisciplinary Association for Psychedelic Studies (MAPS), Canadian companies like
Numinus Wellness Inc. (TSXV:NUMI) (OTCPK:LKYSF),